3 ms·
Now, how to prevent the attempts of big pharma to patent these to make tens of thousand of Indians/Africans pay big $$. These AI modelers are reputedly not vali
by aurizon 1y ago
Now, how to prevent the attempts of big pharma to patent these to make tens of thousand of Indians/Africans pay big $$.
These AI modelers are reputedly not validly a human creation = patent/copyright. These protein constructs might have a long room temp shelf life = needed in most Indian/African bite victims.
- philipkglass 1y agoThese will probably be ignored rather than patented/monopolized by Big Pharma. A few million treatable cases per year globally, concentrated in low-income countries, is a small market to chase. Medical needs in low-income countries need to be addressed by governments or nonprofits rather than for-profit companies. EDIT: replaced "100,000 treatable cases" with "a few million treatable cases" per https://pmc.ncbi.nlm.nih.gov/articles/PMC11020954/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11020954/ referenced by Lol_arco.
- aurizon 1y agoOne hopes a storable and long lasting product will be able to save many of those 100,000 deaths(??), but you are correct - it might not offer enough $$ to USA pharma?
- Lol_arco 1y agoYeah there isn't enough money in it for big pharma. Maybe some other form of funding, but this is the reason why all these tropical diseases are neglected.